SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001999371-24-002377
Filing Date
2024-02-14
Accepted
2024-02-14 20:43:32
Documents
2
Group Members
DEVESH GANDHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP mrsn-sc13g_123123.htm SC 13G 92909
2 JOINT FILING AGREEMENT ex99-a.htm EX-99.(A) 6366
  Complete submission text file 0001999371-24-002377.txt   100951
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 24641681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 20 PARK PLAZA 4TH FLOOR BOSTON MA 02116 617.284.6952
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001816307 (see all company filings)

IRS No.: 834542901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G